Table of Contents
Table of Contents
Preface
Chapter 1. Assay Development for High Throughput Screening
(David Cronk, Mohammed Akhlaq, Sachin Mahale and Joanne Shearer, Charles River Laboratories, Chesterford Research Park, Little Chesterford, Saffron Walden, UK)
Chapter 2. Application of Fluorescence Technologies to High Throughput Screening Assays
(Bolormaa Baljinnyam, Maya L. Gosztyla, Michael Ronzetti, Anton Simeonov and Nathan P. Coussens, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, US)
Chapter 3. Luminescence Technologies for High Throughput Compound Screening
(Eun Jeong Cho and Kevin N. Dalby, College of Pharmacy, University of Texas at Austin, Austin, TX, US)
Chapter 4. Acoustic Mist Ionization Mass Spectrometry (AMI-MS) in High Throughput Screening
(Hannah Semple, Gareth Davies, Marian Preston, Corinne Molyneux, Charles-Hugues Lardeau, Elizabeth Mouchet and Ian Sinclair, Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Macclesfield, Cheshire, UK, and others)
Chapter 5. High Throughput Flow Cytometry: Principles, Practice and Prospects
(Adam Zweifach, Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT, US)
Chapter 6. Perspectives on High Content Imaging as an HTS Technology: Now and in the Future
(James Pilling, Samantha Peel, Elizabeth Mouchet and Guy Williams, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK, and others)
Chapter 7. Biophysical Hit Evaluation
(Scott Pollack, Rupert Satchell, Juliet Morgan and Patrick J. McIntyre, Bioscience Department, Sygnature Discovery, BioCity, Nottingham, UK)
Chapter 8. CETSA in High Throughput Screening
(Joseph Shaw and Lorena A. Kallal, Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK, and others)
Chapter 9. Droplet-Based Microfluidics for High Throughput Screening
(Huiling Yuan, Ran Tu and Qinhong Wang, CAS Key Laboratory of Systems Microbial Biotechnology, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China)
Chapter 10. Encoded Library Technologies as Screening Platforms for Drug Discovery
(Jonas V. Schaefer, Christoph E. Dumelin, Lukas Leder, and Johannes Ottl, Novartis Pharma AG/NIBR/CBT/Chemical Genetics/Encoded Library Technologies, Basel, Switzerland)
Chapter 11. Data Analysis in High Throughput Screening
(Stephan Steigele and Stephan Heyse, Genedata AG, Basel, Switzerland)
Chapter 12. The Application of Iterative Screening to Hit Identification
(Fredrik Svensson, Andreas Bender and Ulf Norinder, Alzheimer’s Research UK UCL Drug Discovery Institute, University College London, London, UK, and others)
About the Editors
Index
Additional Information
Keywords: High Throughput Screening Assay Development